Trimetrexate as a biochemical modulator of 5-fluorouracil and leucovorin in colorectal cancer.
Punt
C J
CJ
Department of Medical Oncology, University Medical Center St Radboud, Nijmegen, The Netherlands.
D000931:Antidotes / Q000627:therapeutic use*; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005472:Fluorouracil / Q000627:therapeutic use*; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use*; D016597:Trimetrexate / Q000627:therapeutic use*
D000931:Antidotes; D000964:Antimetabolites, Antineoplastic; D005493:Folic Acid Antagonists; D002955:Leucovorin; D005472:Fluorouracil; D016597:Trimetrexate